摘要
目的评估改良衰弱指数(mFI)在预测新辅助治疗后行腹腔镜直肠癌手术老年患者短期疗效及肿瘤学结果中的应用。方法收集广州市第一人民医院2012年1月至2018年6月行新辅助治疗后再行腹腔镜直肠癌手术的老年患者147例,依据患者术前mFI评分分为无衰弱组(mFI≤0.29,106例)、衰弱组(mFI>0.29,41例),并对两组患者在人口统计学、手术相关数据、短期临床疗效、术后并发症等指标进行统计分析。结果27.9%的患者被评估为衰弱。衰弱组患者在住院天数、术后并发症均高于非衰弱组患者(13.7±8.6 vs 10.5±3.8 d,P=0.025;20/106 vs 16/14例,P=0.011)。结论mFI过高是预测新辅助治疗后行直肠癌患者术后并发症发生的重要指标,术前对老年结直肠癌患者患者进行mFI评分有助于为临床诊疗提供合理依据,降低术后并发症发生率。
Objective To evaluate the application of modified frailty index(mFI)in predictingshort-term outcomes of elderly patients undergoing laparoscopic rectal cancer surgery after neoadjuvanttherapy.Methods We collected 147 elderly patients who underwent laparoscopic rectal cancer surgeryafter neoadjuvant therapy in Guangzhou First People′s Hospital from January 2012 to June 2018.Accord.ing to the preoperative mFI score,they were divided into non-weakening group(mFI<0.29,106 cases)and weakening group(mFI>0.29,41 cases).The demographic data,operation-related data,shorttermclinical efficacy and postoperative complications of the two groups were analyzed.Statistical analysiswas carried out on the indicators.Results 27.9%of patients were assessed as weak.There were significantdifferences in hospitalization days,post-operative complications between the weakened group and thenon-weakened group(13.7±8.6 vs 10.5±3.8 d,P=0.025;20/106 vs 16/14,P=0.011).ConclusionExcessive mFI is an important index to predict the occurrence of complications after neoadjuvant therapyfor rectal cancer patients.Preoperative mFI score for elderly patients with colorectal cancer is helpful toprovide a reasonable basis for clinical diagnosis and treatment and reduce the incidence of complicationsafter surgery.
作者
王强
钟秉政
魏建昌
WANG Qiang;ZHONG Bingzheng;WEI Jianchang(Department of Gastrointestinal Surgery,Guangzhou First People′s Hospital,Guangzhou Medical University,Guangzhou,Guangdong 510180,China)
出处
《岭南现代临床外科》
2019年第4期392-395,399,共5页
Lingnan Modern Clinics in Surgery
关键词
改良衰弱指数
老年患者
新辅助治疗
腹腔镜直肠癌手术
术后并发症
modified frailty index
aged patient
neoadjuvant therapy
laparoscopic rectal cancersurgery
postoperative complications